Literature DB >> 19219574

Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab.

Michael Marnane, Timothy Lynch, Jaqueline Scott, John Stack, Peter J Kelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19219574     DOI： 10.1007/s00415-009-0077-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Can persistent tumor necrosis factor release lead to refractory sarcoidosis?

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-10       Impact factor: 0.670

2.  Successful treatment of steroid-refractory neurosarcoidosis with infliximab.

Authors:  M Sollberger; F Fluri; T Baumann; S Sonnet; M Tamm; A J Steck; M Brutsche
Journal:  J Neurol       Date:  2004-06       Impact factor: 4.849

3.  Successful treatment with adalimumab in infliximab-resistant Crohn's disease.

Authors:  H Richard Barthel; Thomas Gille; Alfred Halbsguth; Martin Kramer
Journal:  J Gastroenterol Hepatol       Date:  2005-09       Impact factor: 4.029

4.  Adalimumab for treatment of cutaneous sarcoidosis.

Authors:  Michael P Heffernan; David I Smith
Journal:  Arch Dermatol       Date:  2006-01

5.  Increased risk for demyelinating diseases in patients with inflammatory bowel disease.

Authors:  Gauree Gupta; Joel M Gelfand; James D Lewis
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

6.  Treatment of sarcoidosis with infliximab.

Authors:  John D Doty; Joseph E Mazur; Marc A Judson
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

Review 7.  Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.

Authors:  J P Franklin; D P M Symmons; A J Silman
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

8.  Central nervous system sarcoidosis--diagnosis and management.

Authors:  J P Zajicek; N J Scolding; O Foster; M Rovaris; J Evanson; I F Moseley; J W Scadding; E J Thompson; V Chamoun; D H Miller; W I McDonald; D Mitchell
Journal:  QJM       Date:  1999-02
  8 in total
  10 in total

1.  Neurosarcoidosis: unusual presentations and considerations for diagnosis and management.

Authors:  Walid Radwan; Brandon Lucke-Wold; Ibrahim Ahmed Robadi; Kymberly Gyure; Thomas Roberts; Sanjay Bhatia
Journal:  Postgrad Med J       Date:  2016-12-05       Impact factor: 2.401

Review 2.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 3.  Treating Immune-Related Epilepsy.

Authors:  Sonal Bhatia; Sarah E Schmitt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-14       Impact factor: 5.081

4.  Update on bioagent therapy in sarcoidosis.

Authors:  Vincent Cottin
Journal:  F1000 Med Rep       Date:  2010-02-24

Review 5.  Headaches related to rheumatologic disease.

Authors:  Noa Schwartz; Hal J Mitnick; Johannes Nowatzky
Journal:  Curr Pain Headache Rep       Date:  2013-12

6.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

7.  Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Authors:  Jeffrey M Gelfand; Michael J Bradshaw; Barney J Stern; David B Clifford; Yunxia Wang; Tracey A Cho; Laura L Koth; Stephen L Hauser; Jason Dierkhising; NgocHanh Vu; Subramaniam Sriram; Harold Moses; Francesca Bagnato; Jeffrey A Kaufmann; Deidre J Ammah; Tsion H Yohannes; Mark J Hamblin; Nagagopal Venna; Ari J Green; Siddharama Pawate
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

8.  Neurosarcoidosis in a public safety net hospital: a study of 82 cases.

Authors:  James Dorman; Lakshmi Warrior; Vishal Pandya; Ying Sun; Jacob Ninan; William Trick; Helen Zhang; Bichun Ouyang
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 9.  Overview of neurosarcoidosis: recent advances.

Authors:  Renata Hebel; Mirosława Dubaniewicz-Wybieralska; Anna Dubaniewicz
Journal:  J Neurol       Date:  2014-09-07       Impact factor: 4.849

Review 10.  Neurosarcoidosis: a clinical approach to diagnosis and management.

Authors:  Richard T Ibitoye; A Wilkins; N J Scolding
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.